肺気腫の世界市場レポート 2025年

肺気腫の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.9％で60億5,000万米ドルに成長します。予測期間中の成長は、ヘルスケア支出の増加、環境汚染の増加、診断用医療機器の需要増加、自動車交通量の増加、低侵襲処置の需要増加などに起因すると考えられます。この期間の主要動向には、新しい吸入デバイスの開発、戦略的パートナーシップ、個別化医療、遠隔医療、吸入療法の進歩、進行中の医療技術革新などが含まれます。

呼吸器感染症の有病率の増加は、肺気腫市場の成長を促進すると予想されます。呼吸器感染症は、副鼻腔、喉、気道、肺など呼吸器系のさまざまな部分に影響を及ぼします。呼吸器感染症の増加は、汚染、気候変動、抗菌剤耐性、都市化、新しい病原体の出現などの要因に起因しています。これらの感染症は、炎症を引き起こし、組織を損傷し、気道閉塞を増大させることによって肺気腫を悪化させ、これらすべてが肺機能のさらなる悪化を招きます。例えば、2024年11月、米国疾病予防管理センター（CDC）は、米国における結核症例の増加を報告し、2023年には前年比15.6％増の9,633件の結核症例が記録されました。呼吸器感染症は増加の一途をたどっており、肺気腫市場の成長に寄与しています。

肺気腫市場の企業は、肺気腫を含む慢性閉塞性肺疾患（COPD）の治療を改善するために、ホスホジエステラーゼ3とホスホジエステラーゼ4の吸入デュアル阻害剤などのイノベーションに注力しています。これらの薬剤は、気道を弛緩させ、炎症を抑え、肺機能を改善することで、疾患の管理を強化し、患者のQOLを向上させています。例えば、2024年6月、英国の製薬会社Verona Pharma plcは、COPDの維持治療として初めてFDAから承認されたPDE3とPDE4のデュアル吸入阻害剤であるOhtuvayre（ensifentrine）を発売しました。気管支拡大作用と抗炎症作用を併せ持つこの新しい吸入治療は、20年以上ぶりの新しい吸入治療であり、専門薬局を通じて販売される予定です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の肺気腫PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の肺気腫市場：成長率分析
• 世界の肺気腫市場の実績：規模と成長、2019～2024年
• 世界の肺気腫市場の予測：規模と成長、2024～2029年、2034年
• 世界の肺気腫総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の肺気腫市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 中心小葉
• 汎小葉性
• 世界の肺気腫市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬
• 治療
• 手術
• その他
• 世界の肺気腫市場：診断別、実績と予測、2019～2024年、2024～2029年、2034年
• 画像検査
• 肺機能検査
• その他
• 世界の肺気腫市場：合併症別、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 胸部感染症
• 肺虚脱
• 心臓の問題
• 肺の穴
• その他の合併症
• 世界の肺気腫市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院とクリニック
• 外科センター
• その他
• 世界の肺気腫市場、中心小葉性のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 軽度中心小葉性肺気腫
• 中等度中心小葉性肺気腫
• 重度中心小葉性肺気腫
• 世界の肺気腫市場、汎小葉性のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 軽度汎小葉性肺気腫
• 中等度汎小葉性肺気腫
• 重度汎小葉性肺気腫

第7章 地域別・国別分析

• 世界の肺気腫市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の肺気腫市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 肺気腫市場：競合情勢
• 肺気腫市場：企業プロファイル
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Sanofi S.A.
  • AstraZeneca PLC
  • Novartis International AG

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Koninklijke Philips N.V.
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim
• Mylan N.V.
• Olympus Corporation
• ResMed Inc.
• Chiesi Farmaceutici S.p.A.
• University of Chicago Medicine（UChicago Medicine）
• Hikma Pharmaceuticals PLC
• United Therapeutics Corporation
• VIDA Diagnostics Inc.
• Kamada Limited
• Pulmonx Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 肺気腫市場、2029年：新たな機会を提供する国
• 肺気腫市場、2029年：新たな機会を提供するセグメント
• 肺気腫市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Emphysema is a chronic lung disease that causes damage to the air sacs (alveoli) in the lungs, resulting in difficulty breathing. It is a type of chronic obstructive pulmonary disease (COPD), typically caused by smoking or prolonged exposure to air pollutants. As the alveoli weaken and lose their elasticity, air becomes trapped in the lungs, making it difficult to expel carbon dioxide and take in fresh oxygen. This leads to shortness of breath, a chronic cough, and progressively reduced lung function.

The primary types of emphysema are centrilobular and panlobular. Centrilobular refers to damage in the central part of the lung lobule, often seen in centrilobular emphysema. Treatment options for emphysema include medications, therapy, surgery, and other approaches. Diagnosis typically involves imaging tests, lung function assessments, and additional diagnostic procedures. Common complications associated with emphysema include chest infections, lung collapse, heart issues, lung holes, and other related conditions. Treatment typically occurs in hospitals, clinics, surgical centers, and other healthcare facilities.

The emphysema market research report is one of a series of new reports from The Business Research Company that provides emphysema market statistics, including the emphysema industry global market size, regional shares, competitors with the emphysema market share, detailed emphysema market segments, market trends, and opportunities, and any further data you may need to thrive in the emphysema industry. This emphysema market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The emphysema market size has grown strongly in recent years. It will grow from $4.74 billion in 2024 to $4.99 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth during the historic period can be attributed to the rising prevalence of respiratory diseases, the aging population, increased smoking rates, higher levels of air pollution, growing government initiatives, and a larger population of tobacco smokers.

The emphysema market size is expected to see steady growth in the next few years. It will grow to $6.05 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth during the forecast period can be attributed to rising healthcare spending, increasing environmental pollution, higher demand for diagnostic medical devices, growing vehicular traffic, and a greater demand for minimally invasive procedures. Key trends during this period include the development of new inhalation devices, strategic partnerships, personalized medicine, telemedicine, advancements in inhalation therapies, and ongoing medical innovations.

The increasing prevalence of respiratory infections is expected to drive the growth of the emphysema market. Respiratory infections affect various parts of the respiratory system, such as the sinuses, throat, airways, and lungs. The rising number of respiratory infections can be attributed to factors such as pollution, climate change, antimicrobial resistance, urbanization, and the emergence of new pathogens. These infections can worsen emphysema by causing inflammation, damaging tissues, and increasing airway obstruction, all of which lead to further deterioration of lung function. For example, in November 2024, the Centers for Disease Control and Prevention (CDC) reported a rise in tuberculosis (TB) cases in the U.S., with 9,633 cases recorded in 2023, a 15.6% increase from the previous year. As respiratory infections continue to increase, they contribute to the growth of the emphysema market.

Companies in the emphysema market are focusing on innovations such as inhaled dual inhibitors of phosphodiesterase 3 and phosphodiesterase 4 to improve treatment for chronic obstructive pulmonary disease (COPD), including emphysema. These medications help relax the airways, reduce inflammation, and improve lung function, offering enhanced management of the disease and improving patients' quality of life. For instance, in June 2024, Verona Pharma plc, a UK-based pharmaceutical company, introduced Ohtuvayre (ensifentrine), the first inhaled dual PDE3 and PDE4 inhibitor approved by the FDA for COPD maintenance treatment. This novel inhaled therapy, combining bronchodilator and anti-inflammatory effects, marks the first new inhaled treatment in over two decades and is set to be available through specialty pharmacies.

In October 2023, Aileron Therapeutics, a U.S.-based biopharmaceutical company, acquired Lung Therapeutics for an undisclosed amount. This acquisition allows Aileron to expand its pipeline by gaining access to clinical-stage therapies, such as LTI-03, a novel peptide aimed at treating idiopathic pulmonary fibrosis. Lung Therapeutics, a company focused on developing treatments for lung diseases, has developed therapies for conditions such as emphysema, and this acquisition positions Aileron to further address life-threatening lung diseases that currently have limited treatment options.

Major players in the emphysema market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Mylan N.V., Olympus Corporation, ResMed Inc., Chiesi Farmaceutici S.p.A., University of Chicago Medicine (UChicago Medicine), Hikma Pharmaceuticals PLC, United Therapeutics Corporation, VIDA Diagnostics Inc., Kamada Limited, Pulmonx Corporation, Mereo BioPharma Group PLC, Uptake Medical Corporation, and Verona Pharma PLC.

North America was the largest region in the emphysema market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in emphysema report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the emphysema market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The emphysema market consists of revenues earned by entities by providing services such as diagnosis and screening services, oxygen therapy, pulmonary rehabilitation programs, and home healthcare services. The market value includes the value of related goods sold by the service provider or included within the service offering. The emphysema market also includes sales of bronchodilators, corticosteroids, oxygen therapy devices, nebulizers, and pulmonary rehabilitation products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Emphysema Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on emphysema market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for emphysema ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The emphysema market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Centrilobular; Panlobular
• 2) By Treatment: Medication; Therapy; Surgery; Other Treatments
• 3) By Diagnosis: Imaging Test; Lung Function Test; Other Diagnosis
• 4) By Complications: Chest Infections; Collapsed Lung; Heart Problems; Lungs Hole; Other Complications
• 5) By End-user: Hospitals And Clinics; Surgical Center; Other End-users
• Subsegments:
• 1) By Centrilobular: Mild Centrilobular Emphysema; Moderate Centrilobular Emphysema; Severe Centrilobular Emphysema
• 2) By Panlobular: Mild Panlobular Emphysema; Moderate Panlobular Emphysema; Severe Panlobular Emphysema
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca PLC; Novartis International AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Emphysema Market Characteristics

3. Emphysema Market Trends And Strategies

4. Emphysema Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Emphysema Growth Analysis And Strategic Analysis Framework

• 5.1. Global Emphysema PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Emphysema Market Growth Rate Analysis
• 5.4. Global Emphysema Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Emphysema Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Emphysema Total Addressable Market (TAM)

6. Emphysema Market Segmentation

• 6.1. Global Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Centrilobular
• Panlobular
• 6.2. Global Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Therapy
• Surgery
• Other Treatments
• 6.3. Global Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Test
• Lung Function Test
• Other Diagnosis
• 6.4. Global Emphysema Market, Segmentation By Complications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chest Infections
• Collapsed Lung
• Heart Problems
• Lungs Hole
• Other Complications
• 6.5. Global Emphysema Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Surgical Center
• Other End-users
• 6.6. Global Emphysema Market, Sub-Segmentation Of Centrilobular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild Centrilobular Emphysema
• Moderate Centrilobular Emphysema
• Severe Centrilobular Emphysema
• 6.7. Global Emphysema Market, Sub-Segmentation Of Panlobular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild Panlobular Emphysema
• Moderate Panlobular Emphysema
• Severe Panlobular Emphysema

7. Emphysema Market Regional And Country Analysis

• 7.1. Global Emphysema Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Emphysema Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Emphysema Market

• 8.1. Asia-Pacific Emphysema Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Emphysema Market

• 9.1. China Emphysema Market Overview
• 9.2. China Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Emphysema Market

• 10.1. India Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Emphysema Market

• 11.1. Japan Emphysema Market Overview
• 11.2. Japan Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Emphysema Market

• 12.1. Australia Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Emphysema Market

• 13.1. Indonesia Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Emphysema Market

• 14.1. South Korea Emphysema Market Overview
• 14.2. South Korea Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Emphysema Market

• 15.1. Western Europe Emphysema Market Overview
• 15.2. Western Europe Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Emphysema Market

• 16.1. UK Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Emphysema Market

• 17.1. Germany Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Emphysema Market

• 18.1. France Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Emphysema Market

• 19.1. Italy Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Emphysema Market

• 20.1. Spain Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Emphysema Market

• 21.1. Eastern Europe Emphysema Market Overview
• 21.2. Eastern Europe Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Emphysema Market

• 22.1. Russia Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Emphysema Market

• 23.1. North America Emphysema Market Overview
• 23.2. North America Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Emphysema Market

• 24.1. USA Emphysema Market Overview
• 24.2. USA Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Emphysema Market

• 25.1. Canada Emphysema Market Overview
• 25.2. Canada Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Emphysema Market

• 26.1. South America Emphysema Market Overview
• 26.2. South America Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Emphysema Market

• 27.1. Brazil Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Emphysema Market

• 28.1. Middle East Emphysema Market Overview
• 28.2. Middle East Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Emphysema Market

• 29.1. Africa Emphysema Market Overview
• 29.2. Africa Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Emphysema Market Competitive Landscape And Company Profiles

• 30.1. Emphysema Market Competitive Landscape
• 30.2. Emphysema Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. Emphysema Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline PLC
• 31.2. Takeda Pharmaceutical Company Limited
• 31.3. Koninklijke Philips N.V.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Boehringer Ingelheim
• 31.6. Mylan N.V.
• 31.7. Olympus Corporation
• 31.8. ResMed Inc.
• 31.9. Chiesi Farmaceutici S.p.A.
• 31.10. University of Chicago Medicine (UChicago Medicine)
• 31.11. Hikma Pharmaceuticals PLC
• 31.12. United Therapeutics Corporation
• 31.13. VIDA Diagnostics Inc.
• 31.14. Kamada Limited
• 31.15. Pulmonx Corporation

32. Global Emphysema Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Emphysema Market

34. Recent Developments In The Emphysema Market

35. Emphysema Market High Potential Countries, Segments and Strategies

• 35.1 Emphysema Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Emphysema Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Emphysema Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer